<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00345592</url>
  </required_header>
  <id_info>
    <org_study_id>2005_TH</org_study_id>
    <nct_id>NCT00345592</nct_id>
  </id_info>
  <brief_title>TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients</brief_title>
  <acronym>TRADE HF</acronym>
  <official_title>TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Demonstrate the efficacy of the device-based managed therapy to treat atrial tachycardia and
      fibrillation (AT/AF) in patients with CHF indication for implant of a CRT defibrillator and
      to demonstrate the advantage of automatic electrical therapy of atrial arrhythmias compared
      to an in-hospital approach for treatment of symptomatic AT/AF.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Unplanned Hospital Admissions for Cardiac Reasons OR Death of Cardiovascular Causes OR Progression to Chronic Atrial Fibrillation</measure>
    <time_frame>3 years from randomization (39 months total)</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">420</enrollment>
  <condition>Heart Failure, Congestive</condition>
  <arm_group>
    <arm_group_label>Device managed arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device-managed therapy arm. Shock therapy for atrial arrhythmias is delivered automatically from the device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Traditional therapy arm. In this arm, therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment. Therefore, patients who will experience symptoms at home, will refer to their center, eventually hospitalized and treated for atrial arrhythmias.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dual (atrial and ventricular) implantable defibrillator</intervention_name>
    <description>The devices automatically applies therapy (shock) for atrial fibrillation, when atrial fibrillation is confirmed.</description>
    <arm_group_label>Device managed arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dual (atrial and ventricular) implantable defibrillator</intervention_name>
    <description>In hospital application of anti arrhythmic therapies via the device</description>
    <arm_group_label>Traditional arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dual (atrial and ventricular) implantable defibrillator</intervention_name>
    <description>Therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment</description>
    <arm_group_label>Traditional arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic symptomatic HF despite stable, optimal drug therapy

          -  indication for a cardiac resynchronisation device with defibrillator backup according
             to current guidelines

          -  patients implanted with cardiac resynchronization device with dual (atrial and
             ventricular) defibrillation capabilities

        Exclusion Criteria:

          -  Chronic atrial fibrillation

          -  Valvular disease

          -  patients who underwent or are planned for ablation of atrial fibrillation

          -  cerebral vascular accident/transient ischemic attack within 12 months from implant
             which lead to relevant impairment

          -  preexisting unipolar pacemaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianluca Botto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedale S. Anna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luigi Padeletti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituto di Clinica Medica I° e Cardiologia A.O.C. Careggi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istituto di Clinica Medica I° e Cardiologia A.O.C.</name>
      <address>
        <city>Careggi</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedale S. Anna</name>
      <address>
        <city>San Fermo della Battaglia (CO)</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2006</study_first_submitted>
  <study_first_submitted_qc>June 27, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2006</study_first_posted>
  <results_first_submitted>April 4, 2014</results_first_submitted>
  <results_first_submitted_qc>May 13, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 11, 2014</results_first_posted>
  <last_update_submitted>February 27, 2017</last_update_submitted>
  <last_update_submitted_qc>February 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>First patient was enrolled on the 3rd of October, 2006. Last patient was enrolled on the 29th of July 2009, for a total of 420 patients.</recruitment_details>
      <pre_assignment_details>24 subjects were not randomized:
7 died before randomization (causes: 3 cardiac, 2 non-cardiac, 2 unknown);
7 voluntarily withdrew;
5 withdrawn due to AF.
2 had device explanted before randomization;
1 had biventricular pacing turned OFF
1 was withdrawn from the study for inclusion criteria violation;
1 lost to follow up.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Device Managed Arm</title>
          <description>Device-managed therapy arm. Shock therapy for atrial arrhythmias is delivered automatically from the device.
Dual (atrial and ventricular) implantable defibrillator: The devices automatically applies therapy (shock) for atrial fibrillation, when atrial fibrillation is confirmed.</description>
        </group>
        <group group_id="P2">
          <title>Traditional Arm</title>
          <description>Traditional therapy arm. In this arm, therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment. Therefore, patients who will experience symptoms at home, will refer to their center, eventually hospitalized and treated for atrial arrhythmias.
Dual (atrial and ventricular) implantable defibrillator: In hospital application of anti arrhythmic therapies via the device
Dual (atrial and ventricular) implantable defibrillator: Therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="199"/>
                <participants group_id="P2" count="197"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="174"/>
                <participants group_id="P2" count="173"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Device Managed Arm</title>
          <description>Device-managed therapy arm. Shock therapy for atrial arrhythmias is delivered automatically from the device.
Dual (atrial and ventricular) implantable defibrillator: The devices automatically applies therapy (shock) for atrial fibrillation, when atrial fibrillation is confirmed.</description>
        </group>
        <group group_id="B2">
          <title>Traditional Arm</title>
          <description>Traditional therapy arm. In this arm, therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment. Therefore, patients who will experience symptoms at home, will refer to their center, eventually hospitalized and treated for atrial arrhythmias.
Dual (atrial and ventricular) implantable defibrillator: In hospital application of anti arrhythmic therapies via the device
Dual (atrial and ventricular) implantable defibrillator: Therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="199"/>
            <count group_id="B2" value="197"/>
            <count group_id="B3" value="396"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67" spread="10"/>
                    <measurement group_id="B2" value="68" spread="10"/>
                    <measurement group_id="B3" value="67" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="85"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="152"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="311"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="199"/>
                    <measurement group_id="B2" value="197"/>
                    <measurement group_id="B3" value="396"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Unplanned Hospital Admissions for Cardiac Reasons OR Death of Cardiovascular Causes OR Progression to Chronic Atrial Fibrillation</title>
        <time_frame>3 years from randomization (39 months total)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Device Managed Arm</title>
            <description>Device-managed therapy arm. Shock therapy for atrial arrhythmias is delivered automatically from the device.
Dual (atrial and ventricular) implantable defibrillator: The devices automatically applies therapy (shock) for atrial fibrillation, when atrial fibrillation is confirmed.</description>
          </group>
          <group group_id="O2">
            <title>Traditional Arm</title>
            <description>Traditional therapy arm. In this arm, therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment. Therefore, patients who will experience symptoms at home, will refer to their center, eventually hospitalized and treated for atrial arrhythmias.
Dual (atrial and ventricular) implantable defibrillator: In hospital application of anti arrhythmic therapies via the device
Dual (atrial and ventricular) implantable defibrillator: Therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment</description>
          </group>
        </group_list>
        <measure>
          <title>Unplanned Hospital Admissions for Cardiac Reasons OR Death of Cardiovascular Causes OR Progression to Chronic Atrial Fibrillation</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="199"/>
                <count group_id="O2" value="197"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.987</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.684</ci_lower_limit>
            <ci_upper_limit>1.503</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Device Managed Arm</title>
          <description>Device-managed therapy arm. Shock therapy for atrial arrhythmias is delivered automatically from the device.
Dual (atrial and ventricular) implantable defibrillator: The devices automatically applies therapy (shock) for atrial fibrillation, when atrial fibrillation is confirmed.</description>
        </group>
        <group group_id="E2">
          <title>Traditional Arm</title>
          <description>Traditional therapy arm. In this arm, therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment. Therefore, patients who will experience symptoms at home, will refer to their center, eventually hospitalized and treated for atrial arrhythmias.
Dual (atrial and ventricular) implantable defibrillator: In hospital application of anti arrhythmic therapies via the device
Dual (atrial and ventricular) implantable defibrillator: Therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="103" subjects_at_risk="199"/>
                <counts group_id="E2" subjects_affected="93" subjects_at_risk="197"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>atrial fibrillation</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="199"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="197"/>
              </event>
              <event>
                <sub_title>worsening of cardiac disorders</sub_title>
                <description>events leading to death</description>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="199"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="197"/>
              </event>
              <event>
                <sub_title>transplant</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="199"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="197"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>hopspitalizatin/intervention</sub_title>
                <description>including cardiac and non cardiac hospitalizations</description>
                <counts group_id="E1" events="85" subjects_affected="78" subjects_at_risk="199"/>
                <counts group_id="E2" events="74" subjects_affected="58" subjects_at_risk="197"/>
              </event>
              <event>
                <sub_title>worsening of non-cardiac disorders</sub_title>
                <description>events leading to death</description>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="199"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="197"/>
              </event>
              <event>
                <sub_title>worsening of unknown conditions leading to death</sub_title>
                <description>include all the events leading to out of hospital death for unknown or undetermined conditions</description>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="199"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="197"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="199"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="197"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>device reprogramming</sub_title>
                <description>need to change device settings due to patient sysmptoms or adverse device effect, without invasive intervention</description>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="199"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="197"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>clinical observation</sub_title>
                <description>not requiring intervention</description>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="199"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="197"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Giovanni Luca Botto</name_or_title>
      <organization>S. Anna Hospital</organization>
      <phone>0315851 ext +39</phone>
      <email>gluca.botto@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

